Cynata Therapeutics to provide status of stem cell product manufacturing … – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics to provide status of stem cell product manufacturing …
Proactive Investors Australia Its Cymerus™ technology enables large scale production of mesenchymal stem cells from a single, one-time donor – a pivotal requirement for pharmaceutical companies moving into stem cell medicine. Earlier this month, it partner with the University of … |
